| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |